MYRIAD GENETICS INC.

Myriad Genetics to Release Fourth-Quarter 2021 Financial Results on February 24, 2022

16 фев 2022 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics to Present at Two Upcoming Healthcare Conferences

14 фев 2022 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference

05 янв 2022 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service

04 янв 2022 15:47:10 Источник Nasdaq GlobeNewswire

New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey

15 дек 2021 09:47:48 Источник Nasdaq GlobeNewswire

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

15 дек 2021 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer

14 дек 2021 15:05:00 Источник Nasdaq GlobeNewswire

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

23 ноя 2021 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment

22 ноя 2021 06:05:00 Источник Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans

02 ноя 2021 07:30:02 Источник Nasdaq GlobeNewswire